| Initial public offer of upto 29,46,000 equity shares of face value of
Rs. 10/- each (the equity shares) of Accretion Pharmaceuticals Limited (the company or accretion or the issuer) at an issue price of Rs. [*] per equity share for cash, aggregating up to Rs. [*] crores (public issue) out of which 1,47,600 equity shares of face value of Rs. 10 each, at an issue price of Rs. [*] per equity share for cash, aggregating Rs. [*] crores will be reserved for subscription by the market maker to the issue (the market maker reservation portion). The public issue less market maker reservation portion i.e., issue of 27,98,400 equity shares of face value of Rs. 10 each, at an issue price ofRs. [*] per equity share for cash, aggregating upto Rs. [*] crores is herein after referred to as the net issue. The public issue and net issue will constitute 26.50% and 25.17% respectively of the post-issue paid-up equity share capital of our company.
Price Band: Rs. 96 to Rs. 101 per equity share of the face value of Rs. 10
each.
The floor price is 9.6 times of the face value of the equity shares and the cap price is 10.1 times of the face value of the equity shares.
Bids can be made for a minimum of 1200 equity shares and in multiples of 1200 equity shares thereafter.
|